HOME >> BIOLOGY >> NEWS
Worm brings death to coral

THIS much we know: coral bleaching is a modern epidemic that some biologists predict will kill up to half the world's reefs this century as climate change raises sea temperatures. What we have missed is that some bleaching may actually be an infectious disease spread by a worm, a "malaria of the oceans".

Israeli scientists say they have studied a type of coral whose bleaching is triggered by a bacterium, and found that this is carried and transmitted by a coral-feeding worm. If the same is true for other corals, scientists may be able to prevent the disease by targeting the worm vector, just as they control malaria by targeting mosquitoes.

Corals depend on algae inside their bodies to provide carbohydrates and oxygen through photosynthesis. This partnership allows corals to thrive in infertile areas of ocean, and explains why reef communities are so rich. But when water temperature rises, the algae either die or the corals eject them in response to the stress of the heat. Before too long the entire reef turns white. It is unclear how well reefs later recover, and the sharp rise in coral bleaching since the 1980s has sparked dire predictions for their future (see Box).

Most marine biologists agree that bleaching is caused by rising sea temperatures, and the best way to stop it is to cut carbon emissions. But that is an indirect, long-term strategy that may not save reefs in time. Now there may be a more immediate remedy.

In the late 1990s, Yossi Loya and Eugene Rosenberg led a team from Tel Aviv University that found a bacterium that causes coral bleaching. Crucially, it turns out to be more virulent at higher temperatures. "Coral biologists are not microbiologists," says Rosenberg. "They saw the association of bleaching with temperature, but they did not see the bacterium."

The microbe, named Vibrio shiloi, was responsible for bleaching the stony coral Oculina patagonica in the Mediterranean Sea. But researchers were mystified because th
'"/>

Contact: Claire Bowles
claire.bowles@rbi.co.uk
44-207-331-2751
New Scientist
9-Apr-2003


Page: 1 2

Related biology news :

1. New Arizona State center brings science to policy on issues of water resources and urban growth
2. From science fiction to reality: Nanomedicine brings fresh hope to the medical world
3. New diagnostic tool brings effective treatment closer to patients
4. Technique brings immune-based therapies closer to reality
5. Hebrew University research brings higher peanut yields
6. UCSD brings powerful visualization to high school classroom
7. UCR entomologists report bee-dancing brings more food to honeybee colonies
8. Fire and ice: An altered protein brings fever, chills
9. New mighty mice research brings muscle growth closer to reality
10. Florida research shows that for rice, warmer earth brings uncertain future
11. Genetically engineered hemoglobin brings artificial blood a step closer

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Worm brings death coral

(Date:7/24/2014)... - July 24, 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) ... long-term, randomized, active control Phase 3 study of Zerenex ... binder, for the treatment of hyperphosphatemia in patients with ... (PhosphatE binding and iRon delivery with FErric CiTrate in ... of the American Society of Nephrology ( JASN ...
(Date:7/24/2014)... YORK, NY (July 24, 2014) Scientists at ... Institute are one step closer to creating a ... a patient,s own cells. , For the ... (iPS) cells lines from skin samples of patients ... developed an accelerated protocol to induce these stem ...
(Date:7/24/2014)... have decreased by 45% on average over a 35 ... a study on the impact of humans on declining ... benefits invertebrates such as insects, spiders, crustaceans, slugs and ... pest control for crops, decomposition for nutrient cycling, water ... Science and led by UCL, Stanford and ...
Breaking Biology News(10 mins):Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex™ (ferric citrate) long-term Phase 3 study results published in JASN 4NYSCF scientists 1 step closer to cell therapy for multiple sclerosis patients 2Invertebrate numbers nearly halve as human population doubles 2Invertebrate numbers nearly halve as human population doubles 3
(Date:7/25/2014)... A new study by researchers from the University ... tiny nanosystems function, unlocking the potential to create ... study, which has been published in the prestigious ... a novel laser technique to examine in rich ... a small cluster containing an acetylene molecule and ...
(Date:7/25/2014)... 25, 2014 Lawrence Livermore scientists Charles ... Reuters list of " The World's Most Influential Scientific ... the 3,000 researchers who were identified by analyzing citation ... who published the highest-impact work (2002-2012 and 2012-2013). The ... combustion modeling . , "This recognition is a ...
(Date:7/24/2014)... July 24, 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the ... randomized, active control Phase 3 study of Zerenex (ferric ... for the treatment of hyperphosphatemia in patients with end-stage ... binding and iRon delivery with FErric CiTrate in EsrD) ... the American Society of Nephrology ( JASN ). ...
(Date:7/24/2014)...  ECC West Africa, LLC (ECC) signed a contract ... College Hospital (UCH) Ibadan Board of Management for the ... construct, and operate and maintain a new, state-of-the-art Cancer ... the first of the 4-phase project, ECC will conduct ... UCH Ibadan intends to finance and develop the Cancer ...
Breaking Biology Technology:Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster 2Breakthrough laser experiment reveals liquid-like motion of atoms in an ultra-cold cluster 3Scientists Burst onto Influential List for Combustion Research 2Scientists Burst onto Influential List for Combustion Research 3Scientists Burst onto Influential List for Combustion Research 4Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria 2
Cached News: